Anzalone Christopher Richard

EDGAR CIK 0001423029

Arrowhead Pharmaceuticals, Inc. - ARWR

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CEO Director
Chief Executive Officer
Direct Buys
0
$0
0 Shares
Direct Sells
2
($876,122)
-36,664 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
12/18/2024
10b5-1
12/20/2024
Sell
-26,712 @ $21.24
 ($567,486) 3,688,335 (-0.72%) Direct
01/02/2024
10b5-1
01/04/2024
Sell
-9,952 @ $31.01
 ($308,637) 3,715,048 (-0.27%) Direct